Strategic Partnerships PrecisePK has a track record of forming collaborations with healthcare systems and academic institutions (e.g., UC San Diego, Sharp Healthcare, UCSF Benioff Children’s Hospital, Scripps Health) and recent partnerships with Pacific University, Cherokee Indian Hospital, and Spanish hospital network Hospital Universitari Mutua Terrassa. This suggests a sales approach focusing on expanding enterprise-wide deployments and cross-institutional research collaborations.

EHR Integration The product highlights seamless integration with electronic health records to reduce transcription errors and streamline dosing workflows. Target opportunities include hospitals and health systems with modern EHR footprints seeking to enhance dosing accuracy, reduce manual steps, and improve patient safety through Bayesian model-informed dosing.

Bayesian Dosing Lead PrecisePK markets a specialized Bayesian Model-Informed Precision Dosing solution with proven accuracy. There is potential to upsell to larger hospital networks and health systems looking to modernize pharmacotherapy, as well as to expand adoption within oncology, pediatrics, and critical care departments that require individualized dosing for complex patients.

Global Expansion Recent international partnerships (Spain), and collaborations in diverse markets indicate a growth opportunity to scale into new regions and regulatory environments. Focus sales efforts on international deployments, channel partnerships, and localized support to accelerate market entry.

Financial & Scale Fit With reported revenue in the mid tens of millions and a lean employee base, PrecisePK appears positioned for scalable deployments within mid to large health systems. Target budget holders in IT, pharmacy informatics, and clinical operations who oversee clinical decision support, pharmacokinetics software, and EHR-enabled analytics.